September 05-07, 2016 Beijing, China

Theme: Advanced Drug Formulation perspectives for Comprehensive Bioavailability

DoubleTree by Hilton Beijing168 Guang An Men Wai Avenue,Xi Cheng DistrictBeijing, China

Conference Dates:

September,05-07, 2016

Drug formulation-2016 welcomes Students, Pharmaceutical companies /industries, leading universities and research institutions, presenters, andexhibitors from all over the world to Beijing, China. We are delighted to inviteyou all to attend and register for the “Asia Pacific Drug Formulation &Bioavailability Congress” (Drug formulation -2016) which is going to be heldduring September 05-07,2016 at Beijing, China. We invite you to join us atthe Drug Formulation 2016, where you will be sure to have a meaningfulexperience with scholars from around the world. All members of the DrugFormulation 2016 organizing committee look forward to meeting you inBeijing, China.

OMICS International Organizes 300+ Conferences Every Year across USA,Europe & Asia with support from 1000 more scientific societies and Publishes400+ Open access journals which contains over 30000 eminentpersonalities, reputed scientists as editorial board members.

Why China?

China is currently the third largest pharmaceutical market in the world, posting $67billion in revenue in 2011. With an anticipated compound growth rate of 24% between2010 and 2020, China is expected to be the second largest market by 2015. Currently,there are about 1,400 drug companies in China that are, collectively, able to producemore than 60 dosage forms and about 5,000 different types of medicines. The currentChinese market value of the dosage form medicines is worth about $50 B, accountingfor about 5.7% of the global market value. Internally, aiming to transform the Chinesepharmaceutical industry, the Chinese government is encouraging the Chinese drugcompanies to upgrade their manufacturing facility and improve their product quality. Itis therefore believed that the Chinese dosage form drug market will continue to growin a fast pace. It is expected to likely experience a CAGR of about 25% in the next five

years. Its market value could reach more than $158bn in 2016, and expand to 2023.

The global generics sector reached $269.8 billion in 2012. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.

An overview of the global market for generic drug including coverage of therapeutic

Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.The North American market is estimated to reach nearly $73 billion in 2011 and is expected to increase at a 7.9% compound annual growth rate to reach nearly $107 billion in 2016.

The United States is currently spending almost $250 billion a year for prescription drugs. If drugs were sold in a competitive market, without government-imposed patent monopolies, this might achieve savings up to $200 billion a year.

Preformulation & FormulationBiopharmaceutics Classification System

Drug Formulation ProceduresBioavailability Studies & Factors Affecting Bioavailability

Novel Drug Delivery System & Stability Studies

Nutrient & Advances In Bioavailability

Drug Product ManufacturingMedicinal Chemistry & Traditional Medicine

Analytical Method DevelopmentClinical Studies & Contract Research Organizations

All accepted abstracts will be

published in respective OMICS

International Journals.

Journal of Pharmaceutics & Drug Delivery

Research

Drug Designing

Journal of Developing Drugs

Journal of Bioequivalence & Bioavailability

Abstracts will be provided with Digital

Object Identifier by

All accepted abstracts will be published in the

respective Journal

Abstracts will receive a (DOI) provided by CrossRef

Special privileges on group registrations

Opportunity to organize Workshop/Symposia

Global Exposure to your Research

Best poster competition

Young researcher competitions

Abdulmohsen H. Alrohaimi, Dean, School of Pharmacy,

University in Shaqraa, Saudi Arabia.

Peng Li, Scientist in Medicine, University of California, Canada

Weiguo Dai, Scientific Director for Johnson &Johnson , USA

Sinerik Ayrapetyan, Professor in UNESCO, Armenia

Duc P. Do, Associate Professor at Chicago State University

College of Pharmacy, USA

Ibrahim Al-Khars, President at AlAhsa Pharmacy Club, Saudi

Pharmaceutical Society, Saudi Arabia

M. Fawzi Mahomoodally, Professor at University of Mauritius,

Mauritius.

Why to attend Drug Formulation 2016?

Best platform to develop new partnership & collaborations.

Best location to speed up your route into every territory in the

World.

89% our conference attendees are the Key contact in their

labs purchasing decisions.

Our exhibitor booths were visited 4-5 times by 80% of the

attendees during the conference.

Past exhibitor’s feedback reveals ample of enquiries

perceived from the conference attendees.

Network development with both Academia and Business.

Join Our Mailing List

Suggest A Speaker

Suggestions

Invite Proposals